Daniel Bexell

13PUBLICATIONS
81CO-AUTHORS
Molecular targetsPeripheral nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 19, 2026
Combined ATR and mitotic inhibition is effective against MYCN-amplified neuroblastoma.

|Dec 24, 2025
Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.

Katarzyna Radke, Kristina Aaltonen, Erick A Muciño-Olmos

|Jun 25, 2025
Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified Neuroblastoma.

Alexandra Seger, Dora Adamič, Erick Muciño Olmos

|Oct 17, 2024
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma.

Jenny Karlsson, Hiroaki Yasui, Adriana Mañas

|Oct 28, 2022
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance.

Adriana Mañas, Kristina Aaltonen, Natalie Andersson

|Oct 12, 2022
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis.

Ani Grigoryan, Dimitra Zacharaki, Alexander Balhuizen

Pageof 3

Frequent Collaborators

6 joint publications

Kristina Aaltonen

5 joint publications

Adriana Mañas

5 joint publications

Karin Hansson

4 joint publications

Katarzyna Radke